OrphAI Therapeutics Pipeline
| Drug | Indication | Phase |
|---|
| LAM-001 | Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD) | Preclinical/Phase 1 |
| AIT-102 | Transcriptionally Dysregulated Tumors | Preclinical |
| AIT-101 | Amyotrophic Lateral Sclerosis (ALS) | Preclinical |